Please login to the form below
AbbVie and Roche plan Venclexta combo filings in leukaemia
MURANO trial shows the duo’s treatment extends PFS
Teva offloads women's health unit in quickfire deals
The Israeli pharma group is also set to sell its oncology and pain business
CHMP backs maintenance therapy for Tesaro's Zejula
Swiss biotech's PARP inhibitor recommended for approval in ovarian cancer
Bayer bags speedy US approval for lymphoma drug Aliqopa
FDA decision sets the pharma firm up for a showdown with Gilead's Zydelig
Amgen's Mvasi is first FDA-approved cancer biosimilar
Offers prospect of lower-cost alternative to Roche's Avastin
Sandoz says Humira biosimilar clears clinical hurdle
Its drug matches the safety and efficacy of AbbVie’s plaque psoriasis blockbuster
GSK's Shingrix sails through FDA advisory committee
Shingles vaccine data proved safe and effective, says the panel
Roche faces prospect of second Rituxan biosimilar in US
FDA begins its review of Sandoz's version of the immunotherapy treatment
GSK preps COPD filing for asthma pioneer Nucala
Moves despite reporting mixed data for the treatment earlier this year
Forming a picture of health
As life expectancy increases how can stakeholders ensure the last decades of life are healthy ones?
-
SMC gives green light for Amgen’s KyprolisThe committee also gives verdict on three other products
-
Healthcare in the digital ageProf Jan Kimpen on a decade of digital change in healthcare and its future direction of travel
-
Lilly's abemaciclib data leaves potential uncertainMONARCH 3 trial showed similar results to Pfizer’s Ibrance and Novartis’ Kisqali
-
Novartis scores but Roche misses in melanoma trialsPhase III trial combo success for Tafinlar/Mekinist “unprecedented”
-
Teva poaches Lundbeck's Schultz as new CEOShares in Lundbeck fall as two senior posts become vacant
-
Prix Galien opens for entries with new award2018 programme will include new medical technology category
-
NICE: We're the institute of 'yes'But Meindert Boysen says affordability conversations with pharma need to happen earlier
-
AZ buoyed by latest lung cancer data at ESMOData from separate Tagrisso and Imfinzi trials show superior PFS among patients
-
Lilly axes 3,500 jobs in $500m-a-year cost-cutting drive
US drug maker to slash its workforce by 8.5%
Latest appointments
-
Neovii Pharmaceuticals promotes Juergen Pohle to CEOHe will take over from Alexandre Sudarskis in January
-
Cancer Research UK's Karen Vousden to join BMS boardShe will also serve on the pharma firm's Science and Technology Committee
-
Bayer appoints Wolfgang Nickl as chief financial officerHe will succeed Johannes Dietsch on June 1, 2018
-
Paul Stockdale joins Oxford BioDynamics as CFO
He takes over from Katie Long at the UK biotech
-
Ian Weatherhead joins IpsenTakes up corporate communications role at the French pharma firm
Featured jobs
- Director of Rare Diseases, Healthcare Agency, London
-
Excellent Package
- Principal Medical Writer, Medical Communications, London
-
Excellent package
-
Account Director
-
Salary TBC
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
- Senior Medical Writer, Medical Communications, London
-
Excellent package
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35, 000 according to skills and experience
- Editorial Director, Medical Communications, London
-
Excellent package
- Account Executive - Pharma and Life Sciences Brighton or Maccles...
-
Competitive Salary
-
Principal Medical Writer
-
Great salary and benefits
- Senior Account Manager/ Account Director – Pharma and Life Scien...
-
Competitive Salary
-
Programme Director
-
Salary TBC
Subscribe to our email news alerts
- Novartis looks outside pharma for digital transformation
- Roche faces prospect of second Rituxan biosimilar in US
- GSK preps COPD filing for asthma pioneer Nucala
- Sandoz says Humira biosimilar clears clinical hurdle
- Amgen's Mvasi is first FDA-approved cancer biosimilar
- Novartis scores but Roche misses in melanoma trials
PMHub
inVentiv Health Communications
inVentiv Health Communications brings together best-in-class agencies across advertising, digital, public relations, medical communications, research, market access and clinical trial...
Latest intelligence
- Biosimilars: what the future looks like
- Biosimilars: what the future looks like...
- Tightening medical device safety
- European legislators seek to reduce patient exposure to safety risks...
- Research Partnership has published a new Living with Ulcerative Colitis (UC) US market report for 2017
- ...
Quick links
Infographics
